Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Stress-Precipitated Smoking Behavior
NCT00773357Phase 2Completed
- Sponsor
- Yale University
- Start
- Oct 2008
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in nicotine dependence, sponsored by Yale University. Started Oct 2008; status: completed.
02
Drugs
guanfacine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00773357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773357.